SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI8/29/2006 12:32:18 PM
   of 671
 
11:20AM Nastech Pharm awarded development grant for RNAi Therapeutics to prevent and treat influenza (NSTK) 14.93 -0.18 : Co announces that the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, awarded the co a Phase 1 Small Business Innovation Research grant. This award will be used to further develop the co's small-interfering RNA therapeutics to prevent and treat influenza.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News